Loading...
Radioligand Therapy Risks And Pricing Pressures Will Threaten Long Term Earnings Stability
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
25.1%7D
2.9%1Y
25.1%7D
2.9%You can edit this narrative until Dec 9 7:10 PM. Then, changes will post as Updates.